mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
3e-05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |